Want to join the conversation?
$NTRS 2Q15 Q&A: When Blostein of Goldman Sachs asked about operating leverage, Biff told that the Company is focused on maintaining the leverage along with the growth and in 2Q15 drove the Trust fees ratio down and produced 300 points of operating leverage.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.